Description: HUM teams up with Atlas Oncology to make a cancer care model available for its eligible MA members in TN and MS starting in 2026.

Description: LOUISVILLE, Ky., January 13, 2026--Humana expands cancer care for eligible Medicare Advantage members in Tennessee and Mississippi through Atlas Oncology partnership.

Description: LOUISVILLE, Ky., January 12, 2026--CenterWell Pharmacy to dispense obesity management medications as part of new, employer-focused program.

Description: Humana (HUM) has been drawing fresh attention as investors reassess the health insurer’s recent share performance, with the stock showing mixed returns over the past year and over longer multiyear periods. See our latest analysis for Humana. Humana’s recent momentum has picked up, with a 7-day share price return of 4.68% and a 30-day share price return of 7.87%. However, the 3-year total shareholder return of 41.78% and 5-year total shareholder return of 28.76% remain weak. If Humana’s mixed...

Description: Humana's fair value estimate has been nudged from about US$288.46 to roughly US$287.38 per share, reflecting a more cautious stance around how quickly its government managed care businesses might settle into a steadier earnings rhythm. While the discount rate remains essentially unchanged at about 6.96% and revenue growth expectations are now around 9.65%, the mix of bullish and bearish views on Medicare Advantage and Medicaid is keeping opinions split on where the stock should trade. Stay...

Description: LOUISVILLE, Ky., January 09, 2026--Humana Inc. (NYSE: HUM) will release its financial results for the fourth quarter 2025 (4Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on February 11, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026.

Description: Wayfair upgraded, Instacart initiated: Wall Street's top analyst calls

Description: DENVER, January 06, 2026--Cleerly, a leader in AI-based cardiovascular imaging, today announced that Aetna will begin covering Cleerly® LABS plaque analysis effective immediately. Aetna, which covers more than 20+ million lives, joins UnitedHealthcare, Cigna, Humana, BCBS Kansas City, Excellus BCBS, and EviCore in providing coverage for this advanced technology.

Description: Fourth major national payer releases positive comprehensive coverage for AI-powered Heartflow Plaque AnalysisMOUNTAIN VIEW, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis is now covered by Aetna across all lines of business, including Commercial, Medicare Advantage, and Aetna Better Health Medicaid plans. Aetna is the fourth major national commercial ins

Description: If you are wondering whether Humana's current share price still reflects good value, it helps to step back and look at what the recent returns and fundamentals are actually telling you. Humana's stock last closed at US$275.80, with returns of 6.5% over the past week, 7.0% over the past month, 4.3% year to date, 4.7% over the past year, a 40.8% decline over three years, and a 31.7% decline over five years. Taken together, these figures give a mixed picture of recent momentum and longer term...

Description: UNH shares are down 34.5% in a year as costs and margins bite, with Q4 earnings and 2026 guidance set to test whether value is emerging.

Description: HUM sits at a crossroads as Medicare Advantage pressures cap near-term upside, but resilience versus peers argues for patience, not panic.

Description: Why the debate matters.

Description: UnitedHealth puts AI at the core of its strategy to cut administrative waste, speed claims and approvals, and protect margins amid rising healthcare complexity.

Description: At Friday’s news conference announcing the latest drug-pricing deals, Trump said he wants health insurers to “ease up and start cutting prices” as well.

Description: The board of Humana Inc. ( NYSE:HUM ) has announced that it will pay a dividend of $0.885 per share on the 30th of...

Description: Eyebuydirect, the leading online retailer for prescription eyewear, announced that customers can now seamlessly apply their benefits from select vision insurance providers directly at checkout. This new integration enhances Eyebuydirect's mission to make quality eyewear more accessible and offers consumers a simplified way to maximize their eligible benefits when purchasing frames and lenses online. Participating providers currently include EyeMed, Aetna, Humana, and Cigna.

Description: Humana (HUM) has quietly climbed about 11% over the past month, outpacing its performance over the past 3 months and 3 years. That move has investors rechecking what they are really paying for its earnings. See our latest analysis for Humana. Over the past year, Humana’s share price return has been modest compared to its recent 1 month surge, and the far weaker three year total shareholder return suggests this latest momentum may be investors re-rating its earnings power and risk profile. If...

Description: LOUISVILLE, Ky., December 17, 2025--Humana, Nurses on Boards Coalition announce new partnership to mentor emerging nurses.

Description: LOUISVILLE, Ky., December 17, 2025--The Humana Foundation, the philanthropic arm of Humana Inc. for the past 44 years, today announced the publication of its new report, "Strengthening Belonging for Underserved Boys." The report explores how loneliness has become a pressing public health issue among boys, particularly those from racially and ethnically diverse backgrounds, rural communities, LGBTQ+ identities, and boys with differing physical and mental abilities. According to a Gallup poll, 25%

Description: George Renaudin, who has been with Humana for almost 30 years, is retiring, the insurer announced Tuesday. Aaron Martin, previously Amazon’s vice president of healthcare, will take his place.

Description: 🔎 Ford Motor (F): The automaker expects about $19.5 billion in charges as it scales back electric-vehicle ambitions and shifts focus to gas-powered and hybrid vehicles. Shares closed slightly higher but edged lower after hours.

Description: OLDWICK, N.J., December 16, 2025--AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) for the health and dental insurance subsidiaries of Humana Inc. (Humana) (headquartered in Louisville, KY) [NYSE: HUM]. These subsidiaries collectively are referred to as Humana Health Group. In addition, AM Best has affirmed the Long-Term ICR of "bbb" (Good) and the Long-Term Issue Credit Ratings (Long-Term IRs) of

Description: Stocks were mixed Tuesday as U.S. hiring in November was stronger than expected and the unemployment rate jumped to 4.6%. Ford was up 0.2%. The auto maker announced a pivot toward hybrids and away from electric cars.

Description: Pfizer (PFE), Humana (HUM), and Kraft Heinz (KHC) are some of the trending tickers on Yahoo Finance's platform on Tuesday. Market Domination host Josh Lipton and Yahoo Finance Senior Reporter Brooke DiPalma examine the stories driving investor interest in the names. To watch more expert insights and analysis on the latest market action, check out more Market Domination.

Description: Centene, the top ACA Marketplace insurer by membership, and HCA Healthcare, the largest U.S. hospital operator, are among S&P 500 laggards on Tuesday amid reports that House Speaker Mike Johnson won't allow a vote to renew expiring premium subsidies, but he may not have completely shut the door. Politico reported that GOP moderates are still working feverishly to come up with a last-minute solution for renewing the ACA subsidies that can win House passage on Wednesday, despite long odds and contentious debates within the Republican caucus. Humana, the biggest S&P 500 loser on Wednesday, is focused on Medicare Advantage and doesn't offer Affordable Care Act coverage.

Description: Humana stock was falling after the healthcare insurer announced the retirement of its current insurance president and reiterated guidance for this year. Humana shares were down 2.4% in early trading Tuesday. The company said Tuesday that George Renaudin, president of its insurance segment, will retire by the third quarter of 2026.

Description: LOUISVILLE, Ky., December 16, 2025--Humana Inc. (NYSE: HUM) today announced that George Renaudin, Insurance Segment President and member of Humana’s Enterprise Leadership Team, will retire by Q3 2026 following a successful 29-year career at the company. During this period, Renaudin played a pivotal role in establishing and growing Humana’s Medicare Advantage and Medicaid programs, helping to build them into high-performing businesses and assembling a strong insurance leadership team.

Description: UnitedHealth, Humana and Centene have been highlighted in this Industry Outlook article.

Description: The fair value estimate for Humana has nudged higher to about $288 from roughly $287 as analysts factor in slightly stronger long term revenue growth assumptions around 9.5%, supported by improving earnings visibility and steadier Medicare Advantage quality metrics. While the discount rate remains essentially unchanged near 6.96%, reflecting a stable perceived risk profile despite ongoing sector cyclicality, the small upward shift in fair value underscores a cautiously more optimistic view on...

Description: The Medical-HMO industry pursues growth through M&A and tech innovation, aided by easing interest rates, but faces headwinds from rising medical costs, regulatory shifts and a shortage of healthcare professionals. UNH, HUM and CNC are likely to navigate industry storms.

Description: LOUISVILLE, Ky., December 15, 2025--CenterWell partners with Thyme Care for comprehensive cancer care support.

Description: OKLAHOMA CITY, December 10, 2025--Humana Healthy Horizons in Oklahoma selects six nonprofits for community impact awards to address health-related social needs.

Description: UNH is reshaping its model with tech-driven, integrated care as Optum's growth and rising revenues redefine its strategy.

Description: Earlier this month, Humana cut its full-year earnings outlook, citing ongoing pressure in its Medicare Advantage business amid a challenging reimbursement and cost backdrop. At the same time, attention has turned to a possible pharmacy tie-up with Mark Cuban’s low-cost drug venture, which could reshape how Humana’s CenterWell division sources and delivers medications. Next, we’ll examine how the lowered earnings outlook and potential Mark Cuban pharmacy partnership reshape Humana’s...

Description: HOUSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, today announced two new hires to its team for CNSide Diagnostics, LLC, its wholly-owned subsidiary. “We are strategically building the team to bolster our capabilities as we scale up our laboratory operations to address the largely unt

Description: Vancouver, British Columbia--(Newsfile Corp. - December 8, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) ("TempraMed" or the "Company"), a medical technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce a major commercial milestone as part of its broader global expansion strategy: its flagship products, the VIVI Cap and VIVI EPI, are now available through Maccabi Healthcare Services, Israel's second-largest health maintenance...

Description: UnitedHealth's AI-powered virtual assistants aim to simplify claims, boost engagement and deliver faster, more intuitive healthcare support.

Description: Mark Cuban is allegedly looking to partner with Humana on pharmacy offerings.

Description: Wondering if Humana is quietly turning into a value opportunity after a rough stretch, or if the stock is cheap for a reason? Let us break down what the current share price is really telling us. After a tough multi year slide, with the stock still down 50.1% over 3 years and 31.1% over 5 years, Humana has shown signs of life recently, gaining 4.9% over the last week and 2.1% year to date. Investors have been reacting to a mix of headlines around Medicare Advantage dynamics, regulatory...

Description: Health care stocks declined late Friday afternoon, with the NYSE Health Care Index falling 0.3% and

Description: Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Description: Yahoo Finance Senior Reporter Allie Canal joins Market Catalysts to outline some of Wall Street's top analyst calls today: Bank of America's comments on Meta (META), JPMorgan's and Barclays' reactions to Ulta Beauty's (ULTA) big beat on earnings estimates, and Humana (HUM) getting a Buy upgrade. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.

Description: CoreWeave initiated, Unity upgraded: Wall Street's top analyst calls

Description: Humana Inc. ( NYSE:HUM ) has announced that it will pay a dividend of $0.885 per share on the 30th of January. This...

Description: Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index and the Health

Description: Humana stock has underperformed compared to the healthcare services group, but analysts remain fairly bullish about its prospects.

Description: Humana (HUM) has been on a choppy path lately, with the stock slipping over the past 3 months even as profits grow. That gap between earnings momentum and price is what matters now. See our latest analysis for Humana. Over the past year, Humana’s share price has been volatile, with a modest year to date share price return of 1.7 percent but a steeper 3 year total shareholder return of negative 51.8 percent, pointing to fading longer term momentum despite the recent rebound. If Humana’s swings...

Description: Humana and UnitedHealthcare, which granted authorization in November, are the two largest Medicare Advantage providers in the U.S., accounting for 47% of all Medicare Advantage enrollees This latest approval will help enhance timely access to cutting-edge personal exoskeleton solutions for individuals with spinal cord injury Reimbursement coverage is expected to give Lifeward stronger revenue and cash flow dynamics to scale growth MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 03, 2025 (GLOB

Description: UNH trades below its five-year median P/E as it navigates margin pressure, membership declines and strategic divestments.

Description: Most Medicare Advantage enrollees say the extra perks offered by their plans are important, but less than half are taking advantage, a new study finds.

Description: The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Description: UnitedHealth pushes its hybrid care model forward, merging digital tools with in-person care as it extends this approach across global markets.

Description: Wondering if Humana stock is actually a bargain, or if it just looks like one after its recent slide? You are not alone in questioning whether now is a buying opportunity or a value trap. Humana’s share price has dropped sharply, down 21.1% over the last month and nearly 23% in the past year. This signals shifting market sentiment and a newly skeptical investor base. Recent headlines have highlighted major changes in the healthcare landscape. Insurers like Humana are under increased scrutiny...

Description: LOUISVILLE, Ky., November 20, 2025--A recent study conducted by Humana Healthcare Research, with strategic input from researchers at the University of Pennsylvania, reveals key insights into how Medicare Advantage beneficiaries perceive and engage with their supplemental benefits. Results indicate the majority of respondents highly value the benefits they use and agreed supplemental benefits could improve health and save individuals money.

Description: HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today that it has signed a national agreement with Humana, Inc. (NYSE: HUM), effective October 29, 2025, covering approximately 16 million people throughout the United States, to provide the CNSide® Cerebrospinal Fluid (CSF) Tumor Cell Enumeration (TCE) laboratory developed test (LDT). This brings CNSide CSF TCE LDT total pol

Description: LOUISVILLE, Ky., November 19, 2025--The Humana Foundation, the philanthropic arm of Humana Inc. for the past 44 years, today announced the publication of its new issue brief, Senior Food Insecurity in Kentucky: A Growing Public Health Challenge. The brief examines the complex web of challenges the state’s older adults face in accessing nutritious foods and offers a call to action with recommended investments that can help overcome those barriers.

Description: Ariel Investments, an investment management company, released its “Ariel Global Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Global equities rallied in the third quarter, driven by AI enthusiasm, resilient corporate earnings, the first U.S. rate cut of the year, and targeted policy easing across key regions. Against this […]

Description: In early November 2025, Humana Inc. reported third quarter results showing increased revenue to US$32.65 billion, but net income dropped to US$195 million compared to the previous year. The company also completed a US$200 million share buyback and revised its 2025 annual earnings guidance downward to approximately US$12.26 per share. One standout detail is that while revenue continued to rise both in the quarter and year-to-date, Humana’s profitability faced headwinds, leading to a sizable...

Description: LOUISVILLE, Ky., November 18, 2025--CenterWell Home Health branches collect 287,000 meals for needy.

Description: LOUISVILLE, Ky., November 18, 2025--Humana and Epic advance data sharing through digital innovations that align with federal interoperability priorities and improve patient experience.

Description: Routine dental work, vision and long-term care costs can be substantial.

Description: CVS posts record Q3 revenues and a sharp EPS jump, lifting its 2025 outlook, while momentum builds across Aetna, Health Services and Pharmacy.

Description: UnitedHealth shares dipped earlier this week as Trump’s populist healthcare remarks rattled insurers, but fundamentals and long-term guidance may tell a more resilient story.

Description: Although Humana has considerably underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Description: Exploring the Strategic Moves in Chris Davis (Trades, Portfolio)'s Third Quarter 2025 13F Filing

Description: Humana (HUM) shares have seen a modest drop of 5% over the past month, following some turbulence in the healthcare sector. Investors are weighing recent returns alongside the company’s steady annual revenue and income growth. See our latest analysis for Humana. This latest 1-month share price return of -14.9% has knocked some momentum out of Humana, as broader market jitters and sector headwinds linger. With a total shareholder return of -14.4% over the last year, the stock’s longer-term...

Description: Companies in The News Are: TSN, VG, AAL, HUM

Description: Stocks rallied after the Senate advanced a measure designed to end the government shutdown. Magnificent Seven companies and other technology stocks led the way. The Nasdaq composite gained 2.3%, while the S&P 500 rose 1.5% and the Dow industrials climbed 0.8%.

Description: Wall Street was buoyed by investor optimism that the longest federal government shutdown in U.S. history could be nearing an end.

Description: LOUISVILLE, Ky., November 10, 2025--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 44 years, today announced $500,000 in new investments to support food banks and nutrition programs in four states. The funding will help address urgent needs in communities where the loss of food assistance for nearly 42 million Americans, have intensified food insecurity. These and other economic challenges have contributed to a sharp rise in demand for food support.

Description: Also: All the news and watercooler chat from Fortune.

Description: In a conversation with Fortune, Rechtin said the health-insurance giant that primarily serves seniors is "not where we want to be."

Description: LOUISVILLE, Ky., November 06, 2025--Humana Inc. (NYSE: HUM) announced today that Celeste Mellet, Chief Financial Officer, will make a presentation to investors at the Wolfe Research Healthcare Conference on Wednesday, November 19, 2025, at 8:40 a.m. Eastern time.

Description: Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Description: Humana Inc (HUM) maintains a strong EPS outlook while focusing on operational efficiencies and strategic acquisitions to enhance growth and service quality.

Description: Shares in AMD rise after the chip maker posts better-than-expected third-quarter earnings and revenue.

Description: Shares of health insurance company Humana (NYSE:HUM) fell 8.4% in the morning session after the company's third-quarter earnings report revealed a significant miss on profit estimates, fueling concerns about declining profitability. While the company reported revenue of $32.65 billion, beating analysts' expectations, its GAAP earnings per share (EPS) of $1.62 came in 43.4% below the consensus estimate of $2.86. The pressure on profitability was evident as Humana's operating margin fell to 1.2%,

Description: Health care stocks rose Wednesday afternoon, with the NYSE Health Care Index up 0.5% and the Health

Description: HUM tops Q3 earnings forecasts on strong premium growth, even as higher costs and lower memberships weigh on results.

Description: Humana Inc. ( NYSE:HUM ) will pay a dividend of $0.885 on the 30th of January. This payment means the dividend yield...

Description: The insurer reports better-than-expected quarterly earnings and reaffirms its full-year adjusted earnings guidance.

Description: Strong Private Payrolls for October.

Description: ADP marked an improvement of +20K above expectations and a swing to the positive from an upwardly revised -29K the prior month.

Description: Yahoo Finance Senior Reporter Allie Canal takes a look at some of Wednesday's trending tickers and stories. Rivian (RIVN) beat on third quarter earnings results. Humana (HUM) stock is under pressure after the company warned that medical costs are higher than usual. Unity Software (U) stock is surging after the company released third quarter results that beat expectations. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.

Description: The headline numbers for Humana (HUM) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Description: Health insurance company Humana (NYSE:HUM) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 11.4% year on year to $32.65 billion. The company expects the full year’s revenue to be around $128 billion, close to analysts’ estimates. Its GAAP profit of $1.62 per share was 43.4% below analysts’ consensus estimates.

Description: The main US stock measures were tracking in the red in Wednesday's premarket activity as traders awa

Description: Humana (HUM) delivered earnings and revenue surprises of +11.34% and +2.09%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: Humana reported lower third-quarter profit and slashed full-year earnings guidance as medical costs continue to rise, dragging down margins for its core Medicare Advantage business.

Description: Investing.com - Humana has said it expects a decline of membership in its full-year individual Medicare Advantage plans to be lower than previously anticipated, but slashed its unadjusted profit outlook amid heightened medical care costs.

Description: HUM) on Wednesday reported third-quarter profit of $195 million. On a per-share basis, the Louisville, Kentucky-based company said it had profit of $1.62. Earnings, adjusted for non-recurring costs, came to $3.24 per share.

Description: LOUISVILLE, Ky., November 05, 2025--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended September 30, 2025 (3Q25) versus the quarter ended September 30, 2024 (3Q24) and for the nine months ended September 30, 2025 (YTD 2025) versus the nine months ended September 30, 2024 (YTD 2024) as noted in the tables below.

Description: The Medicare giant likes what it’s seen in the first two weeks of open enrollment. But there are steps it can take if membership growth starts getting out of hand, executives said.

Description: The numbers will come at the tail end of what has been a bumpy earnings season for the large managed-care companies.

Description: Humana (HUM) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Description: Humana and USAA Life recently reaffirmed their partnership to continue co-branded Medicare Advantage plans for 2026, announcing the introduction of new mental health benefits including $0 copays for in-network services, with the announcement occurring in late October 2025. This collaboration is designed to support veterans’ mental and physical health, highlighting Humana’s focus on social impact, expanded care, and innovation in insurance coverage. We'll now explore how the expanded...

Description: Curious whether Humana is a hidden gem or an overhyped pick? You are not alone, and we are about to dive deep into what the numbers say about its true worth. Humana’s stock price has seen a slight dip of 4.2% over the past week, though it is still up a notable 10.8% year to date and 11.1% over the last year, hinting at renewed optimism despite recent volatility. Much of this recent movement has been driven by headlines around industry shake-ups and regulatory changes impacting healthcare...

Description: Humana, Cencora and Globus Medical are poised to outshine in the September quarter, driven by strong demand, innovation and volume growth.

Description: Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Humana (HUM), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

Description: The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Description: The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.

Description: Select Medical (SEM) delivered earnings and revenue surprises of +27.78% and +2.87%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: The company said that profit margins for its pharmacy-benefit-services division would slide over the next two years.

Description: UnitedHealth Group's (UNH) stock hasn't received the post-earnings rally that investors may have hoped for, but the medical giant was able to provide subtle signs that its operations are stabilizing.

Description: Cigna has outperformed peers as the managed-care industry faces policy challenges. Affordable Care Act subsidies are set to expire and premiums for next year are up 26%.

Description: On Tuesday, UnitedHealth Group Chief Executive Stephen Hemsley told investors the company is “positioning for durable and accelerating growth in 2026 and beyond.” One way it is doing that: cutting its Medicare business down to size. Bobby Hunter, who oversees UnitedHealth care’s government programs, said the insurer expects its Medicare membership to fall by about one million members next year.

Description: Humana (HUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Description: Healthcare Outcomes Performance Company (HOPCo), the global leader in integrated MSK value-based care solutions, MSK physician practice management, and specialty care clinically integrated networks, and leading health and well-being company, Humana Inc. (NYSE: HUM), have partnered to add Humana members in Arizona to HOPCo's advanced MSK population health solution. This partnership is designed to advance quality of care and help optimize patient health outcomes for eligible individuals living wit

Description: UnitedHealth Group stock rose Tuesday after a slightly better-than-expected quarter for the company’s health insurance division led to a modest earnings beat. The stock jumped more than 4% in the premarket hours, a surprisingly big jump given the results, which were largely in line with expectations. It was an indication of Wall Street’s eagerness to see signs of recovery in the stock, which suffered a historic selloff this spring.

Description: Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Description: Altius, the AI-powered wellbeing infrastructure company led by former Humana and Walmart executives Timothy State and David Hoke, today announced a multi-year exclusive partnership with Syd Life AI, the UK-based pioneer in preventive health technologies, to launch its personalized LLM in the United States.

Description: UnitedHealth (UNH) delivered earnings and revenue surprises of +6.18% and -0.17%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: LOUISVILLE, Ky., October 28, 2025--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on January 30, 2026 to stockholders of record as of the close of business on December 26, 2025.

Description: CNC braces for Q3 results as revenue growth may be offset by rising medical costs and shrinking Medicaid memberships.

Description: Humana (OM:HUM) reported net profit margins of 2%, an increase from 1.1% a year ago, and delivered a sharp year-on-year earnings growth of 93.6% after several years of declines averaging 12.2% per year. The company’s stock currently trades at SEK46, notably below its estimated fair value of SEK163.72, while its price-to-earnings ratio stands at just 10.8x compared to industry averages of 18.9x and 27.2x for peers. Looking ahead, analysts forecast earnings growth of 12.8% per year, outpacing...

Description: UNH's Q3 results hinge on premium growth and Optum gains amid rising costs and margin pressure.

Description: LOUISVILLE, Ky., October 23, 2025--Following World Mental Health Day, the Humana Foundation – the philanthropic arm of Humana Inc. for the past 44 years – along with Jewish Heritage Fund and the University of Louisville’s Christina Lee Brown Envirome Institute, announced the grand opening of the new "Health and Well-being Center" at Junior Achievement (JA) Finance Park of Kentucky. The milestone was marked with a ribbon-cutting ceremony at the Park.

Description: Humana (HUM) shares have seen steady gains over the past month, climbing 12%. Investor sentiment seems to be improving as the company posts solid yearly revenue and net income growth in its latest financials. See our latest analysis for Humana. After this strong run over the past month, Humana’s momentum is unmistakable. The stock has notched an 11.6% share price return in 30 days and is now up nearly 14% year-to-date. While the 12.8% total shareholder return over the past year signals...

Description: MIAMI, October 22, 2025--CarePlus announces Medicare Advantage plan offerings for 2026.

Description: Humana's sharper Medicare focus, cost discipline and leaner structure position it ahead of UnitedHealth in the healthcare stock race.

Description: Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Description: Humana is scheduled to release its fiscal third-quarter earnings next month, and analysts project a double-digit earnings fall.

Description: LOUISVILLE, Ky., October 21, 2025--Humana announces 2026 Medicare Advantage plans designed with veterans in mind. Humana USAA Honor Giveback Plans elevate mental health support.

Description: Shares of health insurance company Humana (NYSE:HUM) jumped 2.3% in the morning session after the company announced a new initiative with Providence, a Washington-based health system, to streamline and secure data exchange in support of value-based care. The collaboration aimed to create a scalable system for seamless data sharing, enabling clinicians to deliver more effective care while reducing administrative tasks for members. Humana's President of Insurance, George Renaudin, stated that the

Description: LOUISVILLE, Ky., October 20, 2025--Humana and Providence launch innovative data exchange collaboration to advance value-based care.

Description: Thinking about what to do with Cigna Group stock right now? You are not alone. Investors have been watching the company’s price movements closely, especially after a rollercoaster year that saw shares climb an impressive 76.3% over five years but fall 9.2% in the past twelve months. This kind of long-term bounce paired with recent softening leaves many asking if there is still value in the stock, or if risks have started to outweigh rewards. Dig a little deeper and the story gets even more...

Description: Millions of seniors with Medicare Advantage plans can expect slimmed-down benefits, loftier premiums, and a reduced selection of options in 2026 plans.

Description: Earlier this week, a Texas judge ruled against Humana in a legal challenge, upholding government-imposed downgrades to Medicare Advantage quality star ratings and confirming cuts to related bonus payments, which could impact billions of dollars in revenue for the company. This court decision introduces significant uncertainty for Humana’s core Medicare Advantage business, as quality ratings are a key factor in determining government reimbursement rates. We'll examine how this legal setback...

Description: Nearly all 55 million Medicare users overpay for prescriptions. Expert Katy Votava explains how to compare Part D plans and save thousands.

Description: The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Description: Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Description: Here is how Beam Therapeutics Inc. (BEAM) and Humana (HUM) have performed compared to their sector so far this year.